Patents-Review.com
ClassID:

91912 ⎘

C07C59/11 - CPC Classification

Classification description:

Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups; Saturated compounds having only one carboxyl group and containing hydroxy or O-metal groups containing rings

Recent Application in this class:
#1
20250109416
2025-04-03

METHOD FOR PRODUCING 3-PHENYLPROPIONIC ACID ANALOGUE COMPOUNDS

 #2
20240124385
2024-04-18

TREPROSTINIL DERIVATIVES AND COMPOSITIONS AND USES THEREOF

 #3
20240116847
2024-04-11

TREPROSTINIL DERIVATIVES AND COMPOSITIONS AND USES THEREOF

 #4
20230219892
2023-07-13

FORMS AND COMPOSITIONS OF A BETA ADRENERGIC AGONIST

 #5
20230107538
2023-04-06

CYCLOALKYL-CONTAINING CARBOXYLIC ACIDS AND USES THEREOF

 #6
20220298268
2022-09-22

Photobase generator, compound, photoreactive composition, and reaction product

 #7
20220055980
2022-02-24

Treprostinil derivatives and compositions and uses thereof

 #8
20210395175
2021-12-23

HYDROXYL COMPOUNDS AND COMPOSITIONS FOR CHOLESTEROL MANAGEMENT AND RELATED USES

 #9
20210355072
2021-11-18

Treprostinil derivatives and compositions and uses thereof

 #10
20200347006
2020-11-05

Treprostinil derivatives and compositions and uses thereof

 #11
20200189999
2020-06-18

CYCLOALKYL-HYDROXYL COMPOUNDS AND COMPOSITIONS FOR CHOLESTEROL MANAGEMENT AND RELATED USES

 #12
20200131108
2020-04-30

Method for synthesizing novel compounds derived from 3-hydroxy-cylopentyl acetic acid

 #13
20200071257
2020-03-05

Treprostinil derivatives and compositions and uses thereof

 #14
20190391488
2019-12-26

Radiation-sensitive resin composition, resist pattern-forming method, acid diffusion control agent, carboxylic acid salt and carboxylic acid

 #15
20190382336
2019-12-19

HYPDH Inhibitors and Methods of Use for the Treatment of Kidney Stones

 #16
20190263742
2019-08-29

Hydroxyl compounds and compositions for cholesterol management and related uses

 #17
20190241499
2019-08-08

Treprostinil derivatives and compositions and uses thereof

 #18
20190084908
2019-03-21

CYCLOALKYL-HYDROXYL COMPOUNDS AND COMPOSITIONS FOR CHOLESTEROL MANAGEMENT AND RELATED USES

 #19
20180305293
2018-10-25

Treprostinil derivatives and compositions and uses thereof

 #20
20180282310
2018-10-04

FORMS AND COMPOSITIONS OF BIARYL INHIBITORS OF BRUTON'S TYROSINE KINASE

 #21
20180170855
2018-06-21

Treprostinil derivatives and compositions and uses thereof

 #22
20180057440
2018-03-01

Method for synthesizing novel compounds derived from 3-hydroxy-cyclopentyl acetic acid

 #23
20180002275
2018-01-04

HYPDH inhibitors and methods of use for the treatment of kidney stones

 #24
20170349516
2017-12-07

Hydroxyl compounds and compositions for cholesterol management and related uses

 #25
20170298001
2017-10-19

Treprostinil derivatives and compositions and uses thereof

 #26
20170260119
2017-09-14

Asymmetrical hydrogenation reaction of ketonic acid compound

 #27
20170073286
2017-03-16

Cycloalkyl-hydroxyl compounds and compositions for cholesterol management and related uses

 #28
20160368855
2016-12-22

Treprostinil derivatives and compositions and uses thereof

 #29
20150344389
2015-12-03

Cycloalkyl-hydroxyl compounds and compositions for cholesterol management and related uses

 #30
20150344388
2015-12-03

Hydroxyl compounds and compositions for cholesterol management and related uses

 #31
20150175519
2015-06-25

Amphiphilic cyclobutenes and cylobutanes

 #32
20140235723
2014-08-21

Cycloalkyl-hydroxyl compounds and compositions for cholesterol management and related uses

 #33
20130289117
2013-10-31

Hydroxyl compounds and compositions for cholesterol management and related uses

 #34
20130253004
2013-09-26

Lysophosphatidic acid receptor antagonists and their use in the treatment fibrosis

 #35
20130040916
2013-02-14

Cycloalkyl-hydroxyl compounds and compositions for cholesterol management and related uses

 #36
20120225908
2012-09-06

Hydroxyl compounds and compositions for cholesterol management and related uses

 #37
20120172337
2012-07-05

Cycloalkyl-hydroxyl compounds and compositions for cholesterol management and related uses

 #38
20120035141
2012-02-09

Cycloalkyl-hydroxyl compounds and compositions for cholesterol management

 #39
20120022117
2012-01-26

Salts or co-crystals of 3-(3-dimethylamino-1-ethyl-2-methyl-propyl)-phenol

 #40
20110178043
2011-07-21

Inhibitors of the mevalonate pathway of

#41
20110150981
2011-06-23

Compounds for use in therapy

 #42
20110003860
2011-01-06

HYDROXYL COMPOUNDS AND COMPOSITIONS FOR CHOLESTEROL MANAGEMENT AND RELATED USES

 #43
20100249451
2010-09-30

PROCESS FOR THE PREPARATION OF SUBSTITUTED BENZILIC ACID FROM SUBSTITUTED BENZILS

 #44
20100209962
2010-08-19

Tetranor PGDM: a biomarker of PGDsynthesis in vivo

 #45
20100179222
2010-07-15

Compositions comprising jasmonic acid derivatives and use of the derivatives

 #46
20100069497
2010-03-18

Compositions comprising jasmonic acid derivatives and use of these derivatives

 #47
20090247489
2009-10-01

Dihydroxyl compounds and compositions for cholesterol management and related uses

 #48
20080249166
2008-10-09

Cycloalkyl-hydroxyl compounds and compositions for cholesterol management

 #49
20080064661
2008-03-13

Dihydroxyl compounds and compositions for cholesterol management and related uses

 #50
20070179120
2007-08-02

Hydroxyl compounds and compositions for cholesterol management and related uses

 #51
20060229281
2006-10-12

Cycloalkyl-hydroxyl compounds and compositions for cholesterol management and related uses

 #52
20050043278
2005-02-24

Hydroxyl compounds and compositions for cholesterol management and related uses